What is the recommended emergency management for acute angioedema?

Emergency Management of Acute Angioedema

Immediately administer intramuscular epinephrine 0.5 mg (1:1000) into the anterolateral thigh for all acute angioedema presentations, while simultaneously assessing airway patency and preparing for potential intubation if upper airway involvement is present. 1

Initial Approach: Assume Histamine-Mediated Until Proven Otherwise

Start with standard anaphylaxis protocols because histamine-mediated angioedema is most common and requires immediate epinephrine. However, you must simultaneously evaluate for bradykinin-mediated causes, as these require completely different management.

Key Clinical Differentiators

Histamine-mediated angioedema:

• Rapid onset (minutes to hours)
• Usually accompanied by urticaria (hives)
• Pruritus present
• Responds to epinephrine, antihistamines, and corticosteroids

Bradykinin-mediated angioedema:

• Slower onset (hours)
• No urticaria (isolated angioedema is rarely allergic) 2
• No pruritus
• Abdominal symptoms more common
• Does NOT respond to epinephrine, antihistamines, or corticosteroids 3

Immediate Management Algorithm

Step 1: Airway Assessment and Stabilization

• Upper airway involvement (face, tongue, oropharynx, larynx) = medical emergency
• Monitor for voice changes, difficulty swallowing, or respiratory distress 3
• Position patient supine if cardiovascular symptoms predominate 1
• Administer oxygen for respiratory distress 1
• Prepare for early intubation or emergency tracheotomy - do not delay if airway compromise is progressing 4

Step 2: First-Line Treatment (All Cases)

• Epinephrine 0.5 mg IM (0.3 mg in children/adolescents) into vastus lateralis 1
• Repeat every 5-15 minutes if symptoms persist 1
• No absolute contraindications for anaphylaxis 1
• Establish IV access and give normal saline bolus if cardiovascular involvement 1

Step 3: Adjunctive Therapy for Histamine-Mediated

• H1 antihistamines (e.g., diphenhydramine 50 mg IV)
• H2 blockers (e.g., ranitidine or famotidine)
• Corticosteroids (e.g., methylprednisolone 125 mg IV or prednisone 50 mg PO) 5
• Inhaled beta-2 agonists if wheezing present 1

Critical caveat: These adjunctive medications should NEVER be given before or instead of epinephrine, and they have no proven role in preventing biphasic reactions 1

Step 4: Recognize Treatment Failure = Bradykinin-Mediated

If proper dosing of epinephrine, antihistamines, and steroids fails to improve symptoms, immediately suspect bradykinin-mediated angioedema 6, 7

Bradykinin-Mediated Angioedema: Specific Management

Common Causes to Identify:

1. ACE inhibitor use (most common drug cause) 3
2. Hereditary angioedema (HAE) - family history, recurrent episodes since childhood/puberty 3
3. Acquired C1-INH deficiency - older age of onset (>40 years) 8
4. DPP-IV inhibitors, neprilysin inhibitors 2

First-Line Treatments for HAE (if available):

All HAE attacks should be treated with HAE-specific agents as early as possible 4, 9:

1. C1-INH concentrate (plasma-derived or recombinant) - IV administration 3
2. Icatibant (bradykinin B2 receptor antagonist) - subcutaneous, can self-administer 3
3. Ecallantide (plasma kallikrein inhibitor) - subcutaneous, requires healthcare provider 3

These are the ONLY effective treatments for HAE attacks - evidence from randomized controlled trials demonstrates clear efficacy 3

If HAE-Specific Agents Unavailable:

Fresh frozen plasma (FFP) 10-15 mL/kg can be used but with important caveats 4:

• Often effective in aborting attacks
• Response time: 90 minutes to 12 hours 4
• Can paradoxically worsen attacks in some patients by providing substrate for contact system activation 3
• Risk of viral transmission and transfusion reactions 3, 4
• Use only when first-line agents unavailable and weigh risks vs. benefits 3

Supportive Care for Bradykinin-Mediated:

• Aggressive IV hydration for abdominal attacks (third-spacing common) 3
• Narcotic analgesia for severe abdominal pain 3
• Antiemetics for nausea/vomiting 3
• Avoid chronic narcotic use - addiction risk in recurrent attacks 3

Observation and Disposition

Observation Period:

• Extended observation (4-6 hours minimum) for patients requiring >1 dose epinephrine or severe initial presentation 1
• Monitor for biphasic reactions (recurrence after initial improvement) 1
• Predictors: wide pulse pressure, unknown trigger, >1 epinephrine dose needed 1

Upper Airway Involvement:

• Mandatory observation in facility capable of emergency airway management 3
• Even with treatment, observe until complete resolution
• Laryngeal attacks can progress to asphyxiation 3

Critical Pitfalls to Avoid

1. Never assume all angioedema is allergic - isolated angioedema without urticaria is rarely allergic 2
2. Don't delay epinephrine while trying to differentiate causes - give it first 1
3. Don't give antihistamines/steroids alone for HAE - they are completely ineffective 3
4. Don't discharge patients with upper airway involvement prematurely 3
5. Don't use FFP as first-line if HAE-specific agents available 3
6. Don't miss ACE inhibitor history - most common cause of bradykinin-mediated angioedema in ED 7
7. Distinguish vasovagal syncope from anaphylaxis: bradycardia + hypotension without pruritus suggests vasovagal 1

Discharge Planning

• Prescribe epinephrine auto-injectors (EpiPen) for histamine-mediated cases 1, 5
• Epinephrine is NOT helpful for C1-INH deficiency angioedema 5
• Refer to allergist/immunologist for definitive diagnosis 10
• For suspected HAE: measure C4, C1-INH antigen, and C1-INH function 3, 8
• Stop ACE inhibitors if suspected cause (may take 1-2 months to see effect) 8